Literature DB >> 11308996

Genetic aspects of pheochromocytoma.

C A Koch1, A O Vortmeyer, S C Huang, S Alesci, Z Zhuang, K Pacak.   

Abstract

We here review the literature on genetics related to pheochromocytoma. About 10 percent of these neuroendocrine tumors are hereditary and are most often associated with multiple endocrine neoplasia type 2 (MEN 2), von Hippel-Lindau disease, and neurofibromatosis type 1 (NF 1). Hereditary tumor syndromes such as the aforementioned ones, are ideal to study the molecular pathogenesis of tumorigenesis as opposed to sporadic tumors in which genetic alterations often merely represent epigenetic tumor progression phenomena. Recent advances in molecular genetics, especially of RET, VHL, NF1, and SDHD, helped better understand the pathogenesis of pheochromocytoma. In this paper, we not only summarize key points of genetic discoveries related to pheochromocytoma, but also report in table format all known RET germline mutations related to pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308996

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  8 in total

Review 1.  The NF1 somatic mutational landscape in sporadic human cancers.

Authors:  Charlotte Philpott; Hannah Tovell; Ian M Frayling; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2017-06-21       Impact factor: 4.639

2.  Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.

Authors:  Mingjian James You; Diego H Castrillon; Boris C Bastian; Rónán C O'Hagan; Marcus W Bosenberg; Ramon Parsons; Lynda Chin; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 3.  Genetic testing for pheochromocytoma.

Authors:  David Karasek; Zdenek Frysak; Karel Pacak
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

4.  Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.

Authors:  George N Zografos; George K Vasiliadis; Flora Zagouri; Chrysanthi Aggeli; Dimitris Korkolis; Sophia Vogiaki; Matina K Pagoni; Gregory Kaltsas; George Piaditis
Journal:  World J Surg Oncol       Date:  2010-03-10       Impact factor: 2.754

5.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

6.  Expression of the p16INK4A/Cdkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens.

Authors:  Peter Muscarella; Mark Bloomston; Alexander R Brewer; Anjali Mahajan; Wendy L Frankel; E Christopher Ellison; William B Farrar; Christopher M Weghorst; Junan Li
Journal:  Gene Expr       Date:  2008

7.  A Case of Multiple Endocrine Neoplasia Type 2B and Gangliomatosis of Gastrointestinal Tract.

Authors:  Banafshe Shahnazari; Aria Aghamaleki; Bagher Larijani; Mohammad Reza Mohajeri Tehrani; Hasan Rafati; Abdolreza Babamahmoodi
Journal:  Case Rep Med       Date:  2012-10-08

Review 8.  Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts.

Authors:  V Dunnett-Kane; E Burkitt-Wright; F H Blackhall; A Malliri; D G Evans; C R Lindsay
Journal:  Ann Oncol       Date:  2020-03-30       Impact factor: 32.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.